Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin and non-Hodgkin lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms.
Biomarker and diagnostic research for lymphoid neoplasm has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
280 publications have been identified in PubMed for lymphoid neoplasm. Research spans Basic Science / Preclinical (33%), Review / Meta-Analysis (20%), and Gene Therapy / Novel Therapeutics (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 93 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 2:11 PM UTC
Research summaries | 55 | 20% |
New treatment approaches | 35 | 13% |
Patient case studies | 33 | 12% |
Disease patterns and progression | 26 | 9% |
Clinical study results | 22 | 8% |
Testing and diagnosis research | 14 | 5% |
Other research | 2 | 1% |
Kaseb H (2026). [PMID: 29763144](https://pubmed.ncbi.nlm.nih.gov/29763144/). *Unknown Journal*. [Review / Meta-Analysis]
Zabaleta A (2026). [PMID: 41610428](https://pubmed.ncbi.nlm.nih.gov/41610428/). *Blood*. [Diagnostic / Biomarker]
Foster KA (2026). [PMID: 41644568](https://pubmed.ncbi.nlm.nih.gov/41644568/). *Nat Commun*. [Basic Science / Preclinical]
Goel N (2026). [PMID: 41090541](https://pubmed.ncbi.nlm.nih.gov/41090541/). *International journal of laboratory hematology*. [Epidemiology / Natural History]
Teja AS (2026). [PMID: 42131661](https://pubmed.ncbi.nlm.nih.gov/42131661/). *Cureus*. [Epidemiology / Natural History]
Rieger L (2026). [PMID: 40638685](https://pubmed.ncbi.nlm.nih.gov/40638685/). *Blood*. [Gene Therapy / Novel Therapeutics]
Kaseb H (2026). [PMID: 33760566](https://pubmed.ncbi.nlm.nih.gov/33760566/). *Unknown Journal*. [Review / Meta-Analysis]
Wang J (2026). [PMID: 41481427](https://pubmed.ncbi.nlm.nih.gov/41481427/). *Gut Microbes*. [Basic Science / Preclinical]
An N (2026). [PMID: 41882404](https://pubmed.ncbi.nlm.nih.gov/41882404/). *Nat Med*. [Clinical Trial Publication]
Hamani S (2026). [PMID: 41967120](https://pubmed.ncbi.nlm.nih.gov/41967120/). *Clin Exp Dermatol*. [Epidemiology / Natural History]